Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Marathon Oil Corporation (NYSE: MRO) closed at $27.40 in the last session, down -1.01% from day before closing price of $27.68. In other words, the price has decreased by -$1.01 from its previous closing price. On the day, 9.12 million shares were traded. MRO stock price reached its highest trading level at $27.86 during the session, while it also had its lowest trading level at $27.33.
Ratios:
We take a closer look at MRO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 102.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.79. For the most recent quarter (mrq), Quick Ratio is recorded 0.35 and its Current Ratio is at 0.40. In the meantime, Its Debt-to-Equity ratio is 0.51 whereas as Long-Term Debt/Eq ratio is at 0.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on April 10, 2024, initiated with a Overweight rating and assigned the stock a target price of $35.
On March 14, 2024, Argus Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $31.
Morgan Stanley Downgraded its Overweight to Equal-Weight on December 11, 2023, whereas the target price for the stock was revised from $27 to $25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when WAGNER PATRICK sold 36,094 shares for $27.65 per share. The transaction valued at 997,887 led to the insider holds 140,829 shares of the business.
Henderson Michael A sold 51,389 shares of MRO for $1,418,051 on Mar 25 ’24. The Executive VP, Operations now owns 114,828 shares after completing the transaction at $27.59 per share. On Mar 22 ’24, another insider, Whitehead Dane E, who serves as the Executive VP and CFO of the company, sold 73,233 shares for $27.06 each. As a result, the insider received 1,981,619 and left with 152,008 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRO now has a Market Capitalization of 15658469376 and an Enterprise Value of 21327208448. As of this moment, Marathon’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.71, and their Forward P/E ratio for the next fiscal year is 8.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.47 while its Price-to-Book (P/B) ratio in mrq is 1.41. Its current Enterprise Value per Revenue stands at 3.305 whereas that against EBITDA is 4.945.
Stock Price History:
Over the past 52 weeks, MRO has reached a high of $30.06, while it has fallen to a 52-week low of $21.63. The 50-Day Moving Average of the stock is 5.76%, while the 200-Day Moving Average is calculated to be 7.41%.
Shares Statistics:
According to the various share statistics, MRO traded on average about 9.96M shares per day over the past 3-months and 9693360 shares per day over the past 10 days. A total of 577.00M shares are outstanding, with a floating share count of 574.93M. Insiders hold about 0.39% of the company’s shares, while institutions hold 78.09% stake in the company. Shares short for MRO as of 1711584000 were 14887967 with a Short Ratio of 1.50, compared to 1709164800 on 12157138. Therefore, it implies a Short% of Shares Outstanding of 14887967 and a Short% of Float of 3.05.
Dividends & Splits
The forward annual dividend rate for MRO is 0.42, which was 0.42 in the trailing 12 months. The stock’s 5-year Average Dividend Yield is 1.6.
Earnings Estimates
The market rating for Marathon Oil Corporation (MRO) is a result of the insights provided by Altria Group, Inc. analysts actively involved in the assessment.The consensus estimate for the next quarter is $125.23, with high estimates of $27.40 and low estimates of $22.87.
Analysts are recommending an EPS of between $Energy and $Energy for the fiscal current year, implying an average EPS of $Healthcare.
